Industry › BioTech

Press Releases

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease

Mar 14, 2025 19:54 HKT/SGT

Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time

Mar 10, 2025 19:24 HKT/SGT

エーザイ、「健康経営銘柄2025」に初選定

Mar 10, 2025 15:45 JST

Register Now: analytica Vietnam's Largest Edition & Must-See Innovations!

Mar 06, 2025 07:32 HKT/SGT

Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan

Mar 05, 2025 08:09 HKT/SGT

Micreos Pharmaceuticals 與生物製劑 CDMO Northway Biotech 合作推動其工程化內溶素療法製造計畫

Mar 04, 2025 23:00 HKT/SGT

Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program

Mar 04, 2025 20:00 HKT/SGT

重磅發佈 - 君聖泰醫藥在JAMA Network Open發表熊去氧膽小檗鹼治療2型糖尿病的臨床2期研究數據療效顯著多重代謝獲益市場前景廣闊

Mar 04, 2025 16:48 HKT/SGT

Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia

Mar 04, 2025 16:22 HKT/SGT

重磅发布 - 君圣泰医药在JAMA Network Open发表熊去氧胆小檗碱治疗2型糖尿病的临床2期研究数据疗效显著多重代谢获益市场前景广阔

Mar 04, 2025 12:32 HKT/SGT

HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open

Mar 04, 2025 12:26 HKT/SGT

佐藤製薬とエーザイ、経口抗真菌剤「ネイリンカプセル100mg」の日本におけるコ・プロモーションについて発表

Mar 04, 2025 10:00 JST

Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters

Mar 03, 2025 14:50 HKT/SGT

"Fatigue Recovery While You Sleep!" Eisai to Launch Designated Quasi-Drug Drink "Chocola BB Nightwell"

Mar 03, 2025 14:41 HKT/SGT

The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease

Mar 03, 2025 12:53 HKT/SGT

エーザイ、指定医薬部外品ドリンク「チョコラBBナイトウェル」新発売

Mar 03, 2025 10:00 JST

Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone

Feb 28, 2025 11:31 HKT/SGT

エーザイ、線維芽細胞増殖因子受容体（FGFR）選択的チロシンキナーゼ阻害剤タスルグラチニブについて中国・香港・マカオ・台湾での開発・販売に関するライセンス契約をSciCloneと締結

Feb 28, 2025 10:00 JST

迪拜高层代表团一行参访君圣泰医药解码中国医药创新范式

Feb 27, 2025 21:01 HKT/SGT

CGFNS International 將更名為 TruMerit

Feb 26, 2025 15:00 HKT/SGT